Envestnet Asset Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
Envestnet Asset Management's TWST Position: Q2 2026 in Review
Envestnet Asset Management increased its Twist Bioscience (TWST) stake by 1.6% in Q2 2026, buying an estimated $69.7K and bringing the position to 66,627 shares worth $6.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2230.
Envestnet Asset Management first reported a position in TWST in Q4 2021 and has held it in 19 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Envestnet Asset Management held 66,627 shares of Twist Bioscience worth $6.85M as of Q2 2026.
- Envestnet Asset Management bought 1,071 Twist Bioscience shares in Q2 2026, an estimated $69.7K.
- Twist Bioscience made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2230 holding.
- Envestnet Asset Management first reported a position in Twist Bioscience in Q4 2021 and has held it in 19 quarters since.
- 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.